These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4688632)

  • 1. Hallucinogenic drug-induced behavior under sensory attenuation. Prediction of response to psilocybin.
    Panton Y; Fischer R
    Arch Gen Psychiatry; 1973 Mar; 28(3):434-8. PubMed ID: 4688632
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of handwriting area to pressure ratios during psilocybin-induced hallucinations.
    Fischer R; Kappeler T; Wisecup P; Thatcher K
    Agents Actions; 1969 Jul; 1(1):42-52. PubMed ID: 5406119
    [No Abstract]   [Full Text] [Related]  

  • 3. Personality trait dependent performance under psilocybin. II.
    Thatcher K; Kappeler T; Wisecup P; Fischer R
    Dis Nerv Syst; 1970 Mar; 31(3):181-92. PubMed ID: 4392526
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache.
    Fanciullacci M; Franchi G; Sicuteri F
    Experientia; 1974 Dec; 30(12):1441-3. PubMed ID: 4442544
    [No Abstract]   [Full Text] [Related]  

  • 5. [The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].
    Jastrzebski M; Bala A
    Psychiatr Pol; 2013; 47(6):1157-67. PubMed ID: 25007546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creative performance and the hallucinogenic drug-induced creative experience or one man's brain-damage is another's creativity.
    Fischer R; Scheib J
    Confin Psychiatr; 1971; 14(3):174-202. PubMed ID: 5144286
    [No Abstract]   [Full Text] [Related]  

  • 7. Psilocybin-induced contraction of nearby visual space.
    Fischer R; Hill R; Thatcher K; Scheib J
    Agents Actions; 1970 Aug; 1(4):190-7. PubMed ID: 5520365
    [No Abstract]   [Full Text] [Related]  

  • 8. Personality trait dependent performance under psilocybin.
    Fischer R; Kappeler T; Wisecup P; Thatcher K
    Dis Nerv Syst; 1970 Feb; 31(2):92-101. PubMed ID: 5438334
    [No Abstract]   [Full Text] [Related]  

  • 9. Psilocybin-induced changes in psychologic function, electroencephalogram, and light-evoked potentials in human subjects.
    Rynearson RR; Wilson MR; Bickford RG
    Mayo Clin Proc; 1968 Mar; 43(3):191-204. PubMed ID: 4384806
    [No Abstract]   [Full Text] [Related]  

  • 10. The perception-hallucination continuum. (A re-examination).
    Fischer R
    Dis Nerv Syst; 1969 Mar; 30(3):161-71. PubMed ID: 4304473
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.
    Pokorny T; Preller KH; Kraehenmann R; Vollenweider FX
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):756-66. PubMed ID: 26875114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and extinction of psilocybin induced transformations of visual space.
    Hill RM; Fischer R
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Sep; 6(5):258-63. PubMed ID: 4794961
    [No Abstract]   [Full Text] [Related]  

  • 13. An electroencephalographic analysis of personality-dependent performance under psilocybin.
    Thatcher K; Wiederholt WC; Fischer R
    Agents Actions; 1971 Apr; 2(1):21-6. PubMed ID: 5129520
    [No Abstract]   [Full Text] [Related]  

  • 14. Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.
    Carter OL; Hasler F; Pettigrew JD; Wallis GM; Liu GB; Vollenweider FX
    Psychopharmacology (Berl); 2007 Dec; 195(3):415-24. PubMed ID: 17874073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of psychodysleptic drug psilocybin on visual perception. Changes in brightness preference.
    Fischer R; Hill RM; Warshay D
    Experientia; 1969 Feb; 25(2):166-9. PubMed ID: 4389138
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of psilocybin on primary process content in language.
    Martindale C; Fischer R
    Confin Psychiatr; 1977; 20(4):195-202. PubMed ID: 608346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of drugs on perception in man.
    Malitz S; Kanzler M
    Res Publ Assoc Res Nerv Ment Dis; 1970; 48():35-53. PubMed ID: 4917959
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.
    Gouzoulis-Mayfrank E; Thelen B; Maier S; Heekeren K; Kovar KA; Sass H; Spitzer M
    Neuropsychobiology; 2002; 45(4):205-12. PubMed ID: 12097810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.
    Kometer M; Cahn BR; Andel D; Carter OL; Vollenweider FX
    Biol Psychiatry; 2011 Mar; 69(5):399-406. PubMed ID: 21126732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unity and covariance of perception and behavior. Perceptual variability: a predictor of psychotomimetic drug-induced behavior.
    Fischer R; Thatcher K; Kappeler T; Wisecup P
    Arzneimittelforschung; 1969 Dec; 19(12):1941-5. PubMed ID: 5395887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.